TYPE 2 DIABETES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Type 2 Diabetes Market, By Drug Class (Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like peptide 1 receptor agonists, Biguanides, Sodium-glucose cotransporter 2 (SGLT2) inhibitors, and Others), By Route of Administration (Oral and Parenteral), By End User (Homecare Settings, Hospitals & Clinics, Academic & Research Institutes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Mar 2024
Code : CMI6792
Pages :163
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Type 2 Diabetes Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing aging population

The aging population is another crucial growth driver for the type 2 diabetes market. As human life expectancy increases worldwide due to advancements in public health and medicine, the geriatric population over 65 years is rising sharply. According to United Nations, between 2015 and 2030, the number of people in the world aged 60 years or over is projected to grow by 56%, from 901 million to 1.4 billion. Region wise too, every continent is witnessing notable surge in their elderly demographic. Aging is a significant risk factor for diabetes as age-related metabolic changes impair body's ability to produce and use insulin efficiently. As people grow older, they tend to gain weight and experience loss of muscle mass, making them more prone to insulin resistance.

Key Players Insights